Flavonoids - Antioxidative compounds and their role in prevention of ischemic heart disease;Flawonoidy - Zwia̧zki o właściwościach antyoksydacyjnych i ich znaczenie w prewencji niedokrwiennej choroby serca

Polski Merkuriusz Lekarski

Volumn 15, Issue 89, 2003, Pages 441-444

  Nowicka, Grazyna ^a   Panczenko Kresowska, Bogumiła ^a  

^a Instytutu Zywnosci i Zywienia   (Poland)

Author keywords

Antioxidation; Ischemic heart disease; Polyphenolic compounds; Prooxidation

Indexed keywords

FLAVONOID; ANTIOXIDANT;

ANTIOXIDANT ACTIVITY; DIET THERAPY; FOOD COMPOSITION; FRUIT; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; REVIEW; SPICE; TEA; VEGETABLE; HEART MUSCLE ISCHEMIA;

ANTIOXIDANTS; FLAVONOIDS; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 0345527022     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Aruoma O.I. i wsp.: Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid. Xenobiotica, 1992, 22, 257.
2. Aviram M. i wsp.: Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL and platelet aggregation: studies in humans. Am. J. Clin. Nutr., 2000, 71, 1062.
3. Aviram M.: Antioxidants in restenosis and atherosclerosis. Curr. Intervent. Cardiol. Rep., 1999, 1, 66.
4. Belinky P.A. wsp.: The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis, 1998, 137, 49.
5. Bialecka M.: Wpływ bioflawonoidȯw i lecytyny na przebieg miażdżycy doṡwiadczalnej u krȯlików. Ann. Acad. Med. Stetin., 1997, 43, 41.
6. Bors W., Michel C., Schikora S.: Interaction of flavonoids with ascorbate and determination of their univalent redox potentials: a pulse radiolysis study. Free Radic. Biol. Med., 1995, 19, 45.
7. Brown C.A. i wsp.: Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Study. J. Epiedemiol. Community Health, 1993, 47, 171.
8. Cos P. i wsp.: Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J. Nat. Prod., 1998, 61, 71.
9. Crawford R.S. i wsp.: Dietary antioxidants inhibit development of fatty streak lesions in the LDL-receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol., 1998, 18, 1506.
10. Day A.P. i wsp.: Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation. Ann. Nutr. Metabol., 1997, 41, 353.
11. de Lorgenil M. i wsp.: Mediteranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infraction: final report of the Lyon Diet Heart Study. Circulation, 1999, 96, 779.
12. de Lorgenil M. i wsp.: Mediteranean dietary pattern in randomized trial prolonged survival and possible reduced cancer rate. Arch. Intern. Med., 1998, 137, 1181.
13. Decker E.A.: Phenolics: Prooxidants or Antioxidants?. Nutr. Rev., 1997, 55, 396.
14. Ferrandiz M.L., Alcaraz M.J.: Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Actions., 1991, 32, 283.
15. Frankel E.N. i wsp.: Interfacial phenomene in the evaluation of antioxidants: bulk oils vs emulsions. J. Agric. Food. Chem., 1994, 42, 1054.
16. Fuhrman B., Aviram M.: Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Current Opinion Lipidol., 2001, 12, 41.
17. Gorinstein S. i wsp.: Moderate consumption beer and positive biochemical changes in patients with coronary atherosclerosis. J. Intern. Med., 1997, 242, 219.
18. Gryglewski R.J. i wsp.: On the mechanism of antithrombotic action of flavonoids. Biochem. Pharmacol., 1987, 36, 317.
19. Hertog M.G., Feskens E.J., Hollman P.C.: Dietary antioxidant flavonolds and the risk of coronary heart disease: The Zupthen Elderly Study. Lancet, 1993, 342, 1007.
20. Hertog M.G. i wsp.: Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer, 1993, 20, 21.
21. Hertog M.G. i wsp.: Flavonoid intake and long-term risk of coronary heart disease and cancer in Seven Countries Study. Arch. Inter. Med., 1995, 155, 381.
22. Hertog M.G.: Flavonoids in wine and tea and prevention of coronary heart disease. W Polyphenols 96, wyd. VercanteronJ., Cheza C., Triand J. Paris INRA, 1998, 117-131.
23. Hollman P.C., Katan M.B.: Dietary flavonoids intake, health effects and bioavailability. Food Chem. Toxicol., 1999, 37, 937.
24. Hollman P.C. i wsp.: Relative bioavailability of the anioxidant flavonoid quercetin from various food in man. FEBS Lett., 1997, 418, 152.
25. Hopie A.I. i wsp.: Effect of different lipid systems on antioxidant activity of rosemary constituents carnosol and carnosic acids with and without alpha-tocopherol. J. Agric. Food. Chem., 1996, 44, 2030.
26. Jużwiak S., Mokrzycki K., Wójcicki J.: Kwercetyna działa przeciwmiażdzycowo u królików. Czynniki Ryzyka, 1999, 1, 67.
27. Landolfi R., Mower R.L., Steiner M.: Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem. Pharmacol., 1984, 33, 1525.
28. Lasheras C., Fernandez S., Patterson A.M.: Mediterranean diet and age with respect to overall survival in institutionalize nonsmoking elderly people. Am. J. Clin. Nutr., 2000, 71, 987.
29. Latito S.B., Fraga O.G.: Catechin prevents human plasma oxidation. Free Radic. Biol. Med., 1998, 24, 435.
30. Miura Y. i wsp.: Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J. Nutr., 2001, 131, 27.
31. Miyagi Y., Miwa K., Inove H.: Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am. J. Cardiol., 197, 80, 1627.
32. Morgan J.F. i wsp.: Complexes of iron with phenolic compounds from soybean nodules and other legume tissues: prooxidant and antioxidant properties. Free Radic. Biol. Med., 1997, 22, 861.
33. Nigdikar S.V. i wsp.: Consumption of red wine polyphenols reduces the susceptibil¡y of low-density lipoproteins to oxidation in vivo. Am. J. Clin. Nutr., 1998, 68, 258.
34. Nijveldt R.J. i wsp.: Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr., 2001, 74, 418.
35. Noroozi M., Angerson W., Leen M.: Effects of flavonoids and vitamn C on oxidative DNA damage to human lymphocytes. Am. J. Clin. Nutr., 1998, 67, 12.
36. Peluso M.: White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer. Carcinogenesis, 2000, 21, 183.
37. Rice-Evans C.A., Miller N.J., Paganga G.: Antioxidant properties of phenolic compounds. Trends. Plant. Sci., 1997, 2, 152.
38. Salen P. i wsp.: Effects of a French Mediterranean Diet on heart transplant recipients with hypercholesterolemia. Am. J. Cardiol., 1994, 73, 825.
39. van het Hof K.H. i wsp.: Consumption of green and black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr., 1997, 66, 1125.
40. Vinson J.A., Dabbagh Y.A: Tea phenols: antioxidant effectiveness of teas, tea components, tea fractions and their binding with lipoproteins. Nutr. Rev., 1998, 18, 1067.
41. Wójcicki J. i wsp.: Ginkgo biloba extract inhibits the development of experimental atherosclerosis in rabits. Phytomedicine, 1994, 1, 33.
42. Yamakoshi J. i wsp.: Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis, 1999, 142, 139.